Alterations of the microRNA network cause neurodegenerative disease

doi:10.1016/j.tins.2008.12.003

Trends in Neurosciences

Volume 32, Issue 4, April 2009, Pages 199-206

https://doi.org/10.1016/j.tins.2008.12.003 Get rights and content

Brain development crucially depends on the integrity of microRNA (miRNA) pathways, which function at the post-transcriptional level as a rheostat of the transcriptome and proteome of the cell. miRNAs are also involved in many other, more specific, aspects of neuronal function such as neurite outgrowth and synapse formation. Complete loss of miRNA expression in the brain leads to neurodegeneration in several animal models. Evidence from patient material is emerging that miRNA dysregulation could, indeed, contribute to neurodegenerative disorders. The translation of proteins previously implicated in familial forms of disease seems to be under control of miRNAs, and changes in miRNAs might explain how these proteins become affected in sporadic neurodegenerative disease. Thus, miRNAs are moving rapidly center stage as key regulators of neuronal development and function in addition to important contributors to neurodegenerative disorder.

Section snippets

Human disease and microRNAs

The discovery of small noncoding microRNAs (miRNAs) has revealed an unexpected and intriguing additional level of fine tuning of the genome. The transcriptome is utilized continuously in different combinations, for instance to generate the complex cellular networks of the brain. Since the initial studies performed in Caenorhabditis elegans 15 years ago [1], it is now clear that miRNA pathways alter and modulate the expression of thousands of genes and contribute to a wide variety of

The basics of miRNA biology

The biogenesis and mode of action of miRNAs are increasingly well understood. Similar to classical protein-coding genes, miRNA genes are embedded in the genome [9] and are transcribed by RNA polymerase II [10] (a subset of miRNAs can be transcribed by RNA polymerase III [11]) (Figure 1). The human genome harbors at least 695 miRNAs (http://microrna.sanger.ac.uk). The genomic location of miRNAs varies and can be found in both intergenic and intragenic and/or intronic regions of protein-coding

miRNAs in neurobiology and relevance for neurodegeneration

The importance of miRNAs in a variety of physiologically relevant processes in the nervous system has now been firmly established [23]. As for many other biological control mechanisms, this has been best studied in embryological development. An abundant and particularly diverse source of miRNAs is present in the mammalian brain, some of which follow a specific pattern of expression during brain development or in neuronal cells differentiating in vitro 24, 25, 26, 27, 28. Initial studies

Exploring the role of miRNAs in neurodegeneration using various experimental paradigms

Several studies have now addressed directly the role of miRNAs in neurodegeneration. In most cases, genetic ablation of Dicer (or other genes in the miRNA biogenesis pathway) was used to reduce or abolish the production of mature miRNAs in the cell or tissue investigated. Studies by Bilen et al. [42] showed a striking enhancement of polyQ toxicity when miRNA maturation in Drosophila and human HeLa cells was suppressed. Obviously, inactivating Dicer is a drastic procedure, and it might not be

Disease-related gene expression and miRNA regulation

Gene-dosage effects are clearly implicated in neurodegenerative disorders. For instance, Aβ precursor protein (APP) gene duplications [51] or trisomy 21 [52] (which provides an extra copy of the APP gene) can cause AD. Gene duplications or triplications of the α-synuclein gene are linked to familial PD 53, 54. It is likely that increased protein expression of APP or α-synuclein contributes directly to the neuropathology associated with these diseases by affecting Aβ-plaque load or inducing

Changes in miRNA expression profiles are associated with neurodegenerative disorders

Global miRNA expression profiles have been well studied in cancer, and changes have been correlated with alterations of important survival pathways and cellular phenotypes. Several genes (such as RAS [65]) central to the disease process are directly regulated by miRNAs, and miRNAs might themselves function also as tumor suppressors or oncogenes. This has stimulated several groups 66, 67, 68, including ours [69], to investigate in an unbiased way changes in miRNA expression profiles in sporadic

Future perspectives and concluding remarks

The hypothesis that miRNAs could be involved in neurodegenerative disorders is intriguing [82], and experiments performed in the fly and mouse demonstrate that the miRNA network is necessary for neuronal survival. Recent studies performed in humans support the idea that changes in miRNA expression profiles or miRNA target sequences could contribute significantly to risk for major neurodegenerative diseases such as AD and PD. Of particular interest, miRNAs seem to participate directly in the

Update

During the reviewing process, a paper by Boissonneault et al. [90] was published confirming the principle that mouse BACE1 expression is affected by changes in miRNA levels.

Acknowledgements

This work was supported by stichting Alzheimer onderzoek (SAO, België; www.alzh.org), the Fund for Scientific Research, Flanders, K.U.Leuven (Geconcerteerde onderzoeksactie and Methusalem grant), Federal Office for Scientific Affairs, Belgium (IUAP P6/43/; www.belspo.be). S.S.H. was supported by a Marie Curie fellowship (from the European community, http://cordis.europa.eu/mariecurie-actions/iif/home.html).

References (93)

R.C. Lee
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Cell
(1993)
L. Ma et al.
Micromanagers of malignancy: role of microRNAs in regulating metastasis
Trends Genet.
(2008)
D.E. Kuhn
Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts
Biochem. Biophys. Res. Commun.
(2008)
L. Peters et al.
Argonaute proteins: mediators of RNA silencing
Mol. Cell
(2007)
A. Eulalio
Getting to the root of miRNA-mediated gene silencing
Cell
(2008)
G. Meister
miRNAs get an early start on translational silencing
Cell
(2007)
Y. Sylvestre
An E2F/miR-20a autoregulatory feedback loop
J. Biol. Chem.
(2007)
F.B. Gao
Posttranscriptional control of neuronal development by microRNA networks
Trends Neurosci.
(2008)
H. Hohjoh et al.
Marked change in microRNA expression during neuronal differentiation of human teratocarcinoma NTera2D1 and mouse embryonal carcinoma P19 cells
Biochem. Biophys. Res. Commun.
(2007)
J.Y. Yu
MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation
Exp. Cell Res.
(2008)

P. Xu

MicroRNAs and the regulation of cell death

Trends Genet.

(2004)

J. Bilen

MicroRNA pathways modulate polyglutamine-induced neurodegeneration

Mol. Cell

(2006)

J.S. Karres

The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila

Cell

(2007)

M.C. Chartier-Harlin

α-synuclein locus duplication as a cause of familial Parkinson's disease

Lancet

(2004)

R. Niwa

The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans

Dev. Biol.

(2008)

G. Wang

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of α-synuclein

Am. J. Hum. Genet.

(2008)

M. Cruts et al.

Loss of progranulin function in frontotemporal lobar degeneration

Trends Genet.

(2008)

S.M. Johnson

RAS is regulated by the let-7 microRNA family

Cell

(2005)

G.A. Calin

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas

Cancer Cell

(2007)

M.P. Mattson et al.

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

Trends Neurosci.

(2003)

J. Tsang

MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals

Mol. Cell

(2007)

W.J. Lukiw

An NF-κB-sensitive microRNA-146a-mediated inflammatory circuit in Alzheimer's disease and in stressed human brain cells

J. Biol. Chem.

(2008)

R. Johnson

A microRNA-based gene dysregulation pathway in Huntington's disease

Neurobiol. Dis.

(2008)

W.X. Wang

Focus on RNA isolation: obtaining RNA for microRNA (miRNA) expression profiling analyses of neural tissue

Biochim. Biophys. Acta

(2008)

H. Hohjoh et al.

Expression profile analysis of microRNA (miRNA) in mouse central nervous system using a new miRNA detection system that examines hybridization signals at every step of washing

Gene

(2007)

A. Care

MicroRNA-133 controls cardiac hypertrophy

Nat. Med.

(2007)

I. Eisenberg

Distinctive patterns of microRNA expression in primary muscular disorders

Proc. Natl. Acad. Sci. U. S. A.

(2007)

B. Yang

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

Nat. Med.

(2007)

J.F. Abelson

Sequence variants in SLITRK1 are associated with Tourette's syndrome

Science

(2005)

D.O. Perkins

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder

Genome Biol.

(2007)

M. Lagos-Quintana

Identification of novel genes coding for small expressed RNAs

Science

(2001)

Y. Lee

MicroRNA genes are transcribed by RNA polymerase II

EMBO J.

(2004)

G.M. Borchert

RNA polymerase III transcribes human microRNAs

Nat. Struct. Mol. Biol.

(2006)

X. Cai

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

RNA

(2004)

R.I. Gregory

The Microprocessor complex mediates the genesis of microRNAs

Nature

(2004)

G. Hutvagner

A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA

Science

(2001)

A.J. Giraldez

Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs

Science

(2006)

O. Hobert

Gene regulation by transcription factors and microRNAs

Science

(2008)

E.V. Makeyev et al.

Multilevel regulation of gene expression by microRNAs

Science

(2008)

J. Kim

A MicroRNA feedback circuit in midbrain dopamine neurons

Science

(2007)

E.A. Miska

Microarray analysis of microRNA expression in the developing mammalian brain

Genome Biol.

(2004)

L.F. Sempere

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

Genome Biol.

(2004)

O. Barad

MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues

Genome Res.

(2004)

M. Kapsimali

MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system

Genome Biol.

(2007)

A.J. Giraldez

MicroRNAs regulate brain morphogenesis in zebrafish

Science

(2005)

T.H. Davis

Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus

J. Neurosci.

(2008)

Cited by (382)

Bright daylight produces negative effects on affective and cognitive outcomes in nocturnal rats
2024, Journal of Photochemistry and Photobiology B: Biology
The daily light/dark cycle affects animals' learning, memory, and cognition. Exposure to insufficient daylight illumination negatively impacts emotion and cognition, leading to seasonal affective disorder characterized by depression, anxiety, low motivation, and cognitive impairment in diurnal animals. However, how this affects memory, learning, and cognition in nocturnal rodents is largely unknown. Here, we studied the effect of daytime light illuminance on memory, learning, cognition, and expression of mRNA levels in the hippocampus, thalamus, and cortex, the higher-order learning centers. Two experiments were performed. In experiment one, rats were exposed to 12 L:12D (12 h light and 12 h dark) with a 10, 100, or 1000 lx daytime light illuminance. After 30 days, various behavioral tests (novel object recognition test, hole board test, elevated plus maze test, radial arm maze, and passive avoidance test) were performed. In experiment 2, rats since birth were raised either under constant bright light (250 lx; LL) or a daily light-dark cycle (12 L:12D). After four months, behavioral tests (novel object recognition test, hole board test, elevated plus maze test, radial arm maze, passive avoidance test, Morris water maze, and Y-maze tests) were performed. At the end of experiments, rats were sampled, and mRNA expression of Brain-Derived Neurotrophic Factor (Bdnf), Tyrosine kinase (Trk), microRNA132 (miR132), Neurogranin (Ng), Growth Associated Protein 43 (Gap-43), cAMP Response Element-Binding Protein (Crebp), Glycogen synthase kinase-3β (Gsk3β), and Tumour necrosis factor-α (Tnf-α) were measured in the hippocampus, cortex, and thalamus of individual rats. Our results show that exposure to bright daylight (100 and 1000 lx; experiment 1) or constant light (experiment 2) compromises memory, learning, and cognition. Suppressed expression levels of these mRNA were also observed in the hypothalamus, cortex, and thalamus. These results suggest that light affects differently to different groups of animals.
MicroRNA-217-5p triggers dopaminergic neuronal degeneration via autophagy activation under Atrazine exposure
2024, Environmental Pollution
Atrazine (ATR) is a widely used agricultural herbicide, and its accumulation in soil and water can cause various environmental health problems. ATR has neurotoxic effects on dopaminergic neurons, which can lead to a Parkinson's disease (PD)-like syndrome. Epigenetics regulates gene expression dynamically through DNA methylation, histone post-translational modification, microRNA (miRNA) interaction, and RNA methylation. MicroRNA (miRNA), representing one of the primary epigenetic mechanisms responsible for regulating gene expression, plays a crucial role in maintaining normal cellular function, while dysregulation of miRNA expression has been observed in PD. This study aims to investigate the regulatory mechanisms of miRNA in ATR exposure. The results show that ATR-exposure significantly upregulates the expression level of miR-217-5p. Both miR-217-5p overexpression and ATR exposure is able to trigger the autophagy process and apoptosis. Conversely, inhibiting the expression of miR-217-5p can reverse the levels of ATR-induced autophagy and apoptosis. Moreover, ATR causes damage to dopaminergic neurons, as indicated by the altered expression of tyrosine hydroxylase and α-synuclein. Taken together, these results suggest that ATR-induced autophagy can accelerate the progression of neurodegenerative diseases and that miR-217-5p is probably an important target involved in ATR-induced dopaminergic damage, shedding important light on the development of a novel strategy for treating neurodegenerative diseases.
miRNA dosage control in development and human disease
2024, Trends in Cell Biology
In mammals, miRNAs recognize target mRNAs via base pairing, which leads to a complex ‘multiple-to-multiple’ regulatory network. Previous studies have focused on the regulatory mechanisms and functions of individual miRNAs, but alterations of many individual miRNAs do not strongly disturb the miRNA regulatory network. Recent studies revealed the important roles of global miRNA dosage control events in physiological processes and pathogenesis, suggesting that miRNAs can be considered as a ‘cellular buffer’ that controls cell fate. Here, we review the current state of research on how global miRNA dosage is tightly controlled to regulate development, tumorigenesis, neurophysiology, and immunity. We propose that methods of controlling global miRNA dosage may serve as effective therapeutic tools to cure human diseases.
Progress in quantum dot-based biosensors for microRNA assay: A review
2023, Analytica Chimica Acta
MicroRNAs (miRNAs) are responsible for post-transcriptional gene regulation, and may function as valuable biomarkers for diseases diagnosis. Accurate and sensitive analysis of miRNAs is in great demand. Quantum dots (QDs) are semiconductor nanomaterials with superior optoelectronic features, such as high quantum yield and brightness, broad absorption and narrow emission, long fluorescence lifetime, and good photostability. Herein, we give a comprehensive review about QD-based biosensors for miRNA assay. Different QD-based biosensors for miRNA assay are classified by the signal types including fluorescent, electrochemical, electrochemiluminescent, and photoelectrochemical outputs. We highlight the features, principles, and performances of the emerging miRNA biosensors, and emphasize the challenges and perspectives in this field.
von Hippel-Lindau-targeting microRNA-143-3p attenuates mitochondrial abnormality via AMPK/PGC-1α axis in Parkinson's disease
2023, Experimental Cell Research
Parkinson's disease (PD) is the second most common neurodegenerative disease characterized by selective loss of dopaminergic neurons. We previously found that inhibition of von Hippel-Lindau (VHL) can alleviate dopaminergic neuron degeneration in PD models via regulation of mitochondrial homeostasis, however, the disease-related alterations of VHL and the regulatory mechanisms of VHL level in PD need to be further investigated. In this study, we found that the levels of VHL were markedly increased in multiple cell models of PD and identified microRNA-143-3p (miR-143-3p) as a promising candidate for regulating VHL expression involved in PD. miR-143-3p directly bound to the 3′untranslated region of human VHL mRNA and inhibited its translation, and exerted neuroprotective effects by improving cell viability, apoptosis and tyrosine hydroxylase abnormality. Furthermore, we demonstrated that miR-143-3p exerted neuroprotection by attenuating mitochondrial abnormality via AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) axis, and AMPK inhibitor abolished the beneficial effects of miR-143-3p on the cell model of PD. Therefore, we identify the dysregulated VHL and miR-143-3p in PD, and propose the therapeutic potential of miR-143-3p to alleviate PD by improving mitochondrial homeostasis via AMPK/PGC-1α axis.
Single-molecule/particle counting for microRNA detection and imaging
2023, TrAC - Trends in Analytical Chemistry
MicroRNAs (miRNAs) are responsible for post-transcriptional gene expression regulation and they widely participate in different cell development processes. Dysregulation of miRNAs levels may interfere normal gene regulation to cause diverse human diseases including cancers. The accurate and sensitive detection of miRNAs are highly valuable for disease dignosis, prognosis, and therepy. Single-molecule fluorescence detection is an advanced bioanalysis technology with the characteristics of simplicity, minimum sample consumption, ultrahigh sensitivity, and rapid assay time. Single-molecule counting allows accurate quantification of interested target via simply counting the numbers of individual fluorescent bursts. With the introduction of nanomaterials as the fluorescent labels/fluorescent probe carriers, single-molecule counting can be extended to single-particle counting with the capability of counting the numbers of individual fluorescent particles for target quantification. Herein, we review the advances in single-molecule/particle counting for in vitro and in vivo microRNA detection and imaging, and sumarize their principles, features, and biomedical applications. We highlight the future directions in the field as well.

View all citing articles on Scopus

View full text

Trends in Neurosciences

ReviewAlterations of the microRNA network cause neurodegenerative disease

Section snippets

Human disease and microRNAs

The basics of miRNA biology

miRNAs in neurobiology and relevance for neurodegeneration

Exploring the role of miRNAs in neurodegeneration using various experimental paradigms

Disease-related gene expression and miRNA regulation

Changes in miRNA expression profiles are associated with neurodegenerative disorders

Future perspectives and concluding remarks

Update

Acknowledgements

Cell

Trends Genet.

Biochem. Biophys. Res. Commun.

Mol. Cell

Cell

Cell

J. Biol. Chem.

Trends Neurosci.

Biochem. Biophys. Res. Commun.

Exp. Cell Res.

Trends Genet.

Mol. Cell

Cell

Lancet

Dev. Biol.

Am. J. Hum. Genet.

Trends Genet.

Cell

Cancer Cell

Trends Neurosci.

Mol. Cell

J. Biol. Chem.

Neurobiol. Dis.

Biochim. Biophys. Acta

Gene

MicroRNA-133 controls cardiac hypertrophy

Nat. Med.

Distinctive patterns of microRNA expression in primary muscular disorders

Proc. Natl. Acad. Sci. U. S. A.

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

Nat. Med.

Sequence variants in SLITRK1 are associated with Tourette's syndrome

Science

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder

Genome Biol.

Identification of novel genes coding for small expressed RNAs

Science

MicroRNA genes are transcribed by RNA polymerase II

EMBO J.

RNA polymerase III transcribes human microRNAs

Nat. Struct. Mol. Biol.

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

RNA

The Microprocessor complex mediates the genesis of microRNAs

Nature

A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA

Science

Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs

Science

Gene regulation by transcription factors and microRNAs

Science

Multilevel regulation of gene expression by microRNAs

Science

A MicroRNA feedback circuit in midbrain dopamine neurons

Science

Microarray analysis of microRNA expression in the developing mammalian brain

Genome Biol.

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

Genome Biol.

MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues

Genome Res.

MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system

Genome Biol.

MicroRNAs regulate brain morphogenesis in zebrafish

Science

Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus

J. Neurosci.

Review
Alterations of the microRNA network cause neurodegenerative disease